PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Quantitative Imaging Assessment of Tumor Response to Chemoradiation 
in Lung Cancer.

Abstract Precision medicine demands accurate assessment of tumor response to therapies with the purpose of timely optimization or adjustment of the given treatment regimens. Chemoradiation remains the standard of care in advanced lung cancers and imaging-based noninvasive response evaluation could improve therapeutic efficacy and reduce treatment-related severe side effects. In this review, we overviewed the applications and pitfalls of major imaging modalities in response evaluation in lung cancer from a quantitative perspective. The development of radiomics will provide more precise information for treatment predicting, evaluation and prognosis.
PMID
Related Publications

Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology.

Radiologic-pathologic correlation of response to chemoradiation in resectable locally advanced NSCLC.

MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays.

Radiomics of pulmonary nodules and lung cancer.

Monitoring response to treatment in patients utilizing PET.

Authors

Mayor MeshTerms
Keywords
Journal Title zhongguo fei ai za zhi = chinese journal of lung cancer
Publication Year Start




PMID- 28641699
OWN - NLM
STAT- In-Process
DA  - 20170623
LR  - 20170623
IS  - 1999-6187 (Electronic)
IS  - 1009-3419 (Linking)
VI  - 20
IP  - 6
DP  - 2017 Jun 20
TI  - [Quantitative Imaging Assessment of Tumor Response to Chemoradiation in Lung
      Cancer].
PG  - 407-414
LID - 10.3779/j.issn.1009-3419.2017.06.07 [doi]
AB  - Precision medicine demands accurate assessment of tumor response to therapies
      with the purpose of timely optimization or adjustment of the given treatment
      regimens. Chemoradiation remains the standard of care in advanced lung cancers
      and imaging-based noninvasive response evaluation could improve therapeutic
      efficacy and reduce treatment-related severe side effects. In this review, we
      overviewed the applications and pitfalls of major imaging modalities in response 
      evaluation in lung cancer from a quantitative perspective. The development of
      radiomics will provide more precise information for treatment predicting,
      evaluation and prognosis.
FAU - Jiao, Yuxin
AU  - Jiao Y
AD  - Department of Radiology Oncology;Department of Radiology, Fudan University
      Huadong Hospital, Shanghai 200040, China.
FAU - Ren, Yanping
AU  - Ren Y
AD  - Department of Radiology Oncology, Fudan University Huadong Hospital, Shanghai
      200040, China.
FAU - Zheng, Xiangpeng
AU  - Zheng X
AD  - Department of Radiology Oncology;Zhang Guozhen Diagnosis and Treatment Center of 
      Micronodular Lung Cancer (DTC-MLC), Fudan University Huadong Hospital, Shanghai
      200040, China.
LA  - chi
PT  - English Abstract
PT  - Journal Article
PL  - China
TA  - Zhongguo Fei Ai Za Zhi
JT  - Zhongguo fei ai za zhi = Chinese journal of lung cancer
JID - 101126433
EDAT- 2017/06/24 06:00
MHDA- 2017/06/24 06:00
CRDT- 2017/06/24 06:00
AID - 10.3779/j.issn.1009-3419.2017.06.07 [doi]
PST - ppublish
SO  - Zhongguo Fei Ai Za Zhi. 2017 Jun 20;20(6):407-414. doi:
      10.3779/j.issn.1009-3419.2017.06.07.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>